Involved in O-antigen modification. This enzyme catalyzes the transfer of a glucose residue from UDP-glucose to a lipid carrier.
KEGG: vg:1262848
Salmonella phage P22 gtrB functions as a bactoprenol glucosyltransferase that catalyzes the transfer of glucose molecules from UDP-glucose to undecaprenyl-pyrophosphate (UnDP) lipid carriers. This 933-bp open reading frame encodes a protein with a molecular mass of approximately 35,130 Da and an isoelectric point of 8.8. Structurally, gtrB contains two transmembrane domains primarily located in the latter two-thirds of the protein, suggesting both the amino and carboxy termini maintain cytoplasmic orientation . The protein's enzymatic activity represents the initial step in a coordinated process that ultimately results in the modification of bacterial O-antigens during glycosylation.
The gtrB protein functions as part of a three-gene cassette (gtrABC) that collectively mediates O-antigen modification. Within this system, gtrB transfers glucose to the undecaprenyl-pyrophosphate lipid carrier, while gtrA functions as a flippase that translocates the UnDP-glucose complex across the inner membrane into the periplasmic space . The final step is performed by gtrC, which transfers the glucose molecule from the lipid carrier to a specific position on the growing O-antigen chain . This coordinated process occurs during O-antigen synthesis before attachment to the lipid A core. The complete pathway can be visualized as:
GtrB: Transfers glucose from UDP-glucose to UnDP (cytoplasmic side)
GtrA: Flips UnDP-glucose across the inner membrane
GtrC: Transfers glucose from UnDP to the O-antigen (periplasmic side)
Expression of the gtrABC operon, including gtrB, is regulated through a phase variation mechanism that is dependent on Dam methylation and OxyR. This regulatory system involves:
Two pairs of GATC sites upstream of the gtrA transcriptional start site
Three overlapping OxyR binding sites
Differential methylation patterns that determine promoter activity
When the downstream GATC pair is methylated, OxyR binding is prevented, allowing RNA polymerase access to the promoter and enabling transcription. Conversely, when the upstream GATC pair is methylated, OxyR binds to the downstream GATC sites, blocking RNA polymerase binding and preventing transcription . This creates a heterogeneous bacterial population with varying expression levels of the gtr genes, potentially serving as a virulence strategy to evade host immune responses.
For recombinant expression of gtrB, E. coli-based systems have proven effective, particularly when optimized for membrane protein expression. Based on research methodologies, successful expression typically involves:
| Expression Parameter | Recommended Approach |
|---|---|
| Host strain | E. coli TOP10 cells or BL21(DE3) for high-yield production |
| Vector | pBAD or pET series with appropriate promoter strength |
| Induction | Low IPTG/arabinose concentration (0.1-0.5 mM) |
| Temperature | 25-30°C post-induction |
| Media | LB supplemented with 1% glucose |
| Extraction | Membrane fractionation with mild detergents |
When designing expression constructs, incorporation of affinity tags (His6 or Strep-tag) at the C-terminus is generally preferred to avoid interference with the N-terminal membrane interaction domains. Temperature optimization is particularly critical due to the hydrophobic nature of the transmembrane regions .
Purification of functional gtrB requires specialized approaches to maintain the native conformation of this membrane-associated protein:
Membrane isolation by ultracentrifugation (100,000 × g for 1 hour)
Solubilization with appropriate detergents (n-dodecyl β-D-maltoside or digitonin at 1-2%)
Affinity chromatography using immobilized metal affinity chromatography (IMAC)
Size exclusion chromatography to remove aggregates
Detergent exchange to milder alternatives for activity assays
Activity retention can be monitored through in vitro transferase assays using radiolabeled UDP-glucose and synthetic lipid substrates. Enzyme stability is typically enhanced by maintaining the protein at concentrations above 1 mg/mL and including glycerol (10-15%) in storage buffers.
Analysis of gtrB protein sequence reveals important structural elements that contribute to its specific recognition of UDP-glucose and undecaprenyl-phosphate substrates:
| Domain/Motif | Position | Proposed Function |
|---|---|---|
| Transmembrane domains | C-terminal region | Membrane anchoring and substrate access |
| DxD motif | Conserved across homologs | Coordination of divalent cations for catalysis |
| Hydrophobic pocket | Multiple regions | Accommodation of the lipid substrate |
| UDP-binding domain | N-terminal region | Recognition of the nucleotide sugar donor |
Comparative sequence analysis with homologous proteins from Shigella phages SfII, SfV, and SfX shows 86% sequence identity to a hypothetical 34.6-kDa protein (YFDH_ECOLI) associated with a defective prophage in the E. coli genome . This high degree of conservation suggests strong selective pressure on maintaining specific structural features required for function.
The functional relationship between gtrB and its partner proteins (gtrA and gtrC) involves complex membrane-associated interactions:
GtrB likely forms oligomeric complexes within the inner membrane
Direct protein-protein interactions with gtrA facilitate efficient transfer of the glucose-labeled lipid carrier
Co-localization with gtrC may create a functional "assembly line" for O-antigen modification
These interactions can be studied using techniques such as bacterial two-hybrid assays, co-immunoprecipitation, and fluorescence resonance energy transfer (FRET). Research has demonstrated that while gtrC(II) can function independently, most gtrC variants require the presence of functional gtrAB proteins to mediate O-antigen modification , highlighting the interdependence of these components.
Recombinant gtrB provides a valuable tool for investigating the mechanisms of O-antigen modification in various bacterial systems:
Heterologous expression in different Salmonella serovars to study O-antigen adaptability
Site-directed mutagenesis to identify critical residues for substrate recognition
In vitro reconstitution of complete gtrABC systems to study coordinated O-antigen modification
Development of inhibitors targeting glycosyltransferases as potential antimicrobial agents
Experimental approaches typically involve LPS extraction and analysis by SDS-PAGE, silver staining, and Western blotting with specific antibodies against modified epitopes. Mass spectrometry can provide detailed structural information about the modified O-antigens .
The modification of O-antigens through the action of gtrB and its partner proteins has significant implications for bacterial pathogenesis:
Serotype conversion from 4,12 to 1,4,12 in Salmonella Typhimurium
Prevention of phage binding to lysogenized bacteria
Potential evasion of host immune recognition
Altered surface properties affecting adhesion and colonization
Research has demonstrated that lysogenization by P22 results in the addition of an α-linked glucosyl residue to the 6 position of galactose moieties in the LPS O-antigenic tetrameric repeat . This modification contributes to the phenomenon known as lysogenic conversion, which can protect bacteria from subsequent phage infection and potentially modulate interactions with host immune systems.
Sequence analysis reveals remarkable conservation of gtrB across different phage and bacterial systems:
| Organism/Phage | Protein | Identity to P22 gtrB | Function |
|---|---|---|---|
| Shigella phage SfII | GtrB | High similarity | Serotype conversion |
| Shigella phage SfV | GtrB | High similarity | Serotype conversion |
| Shigella phage SfX | GtrB | High similarity | Serotype conversion |
| E. coli (prophage) | YFDH_ECOLI | 86% | Putative dolichol-phosphate mannosyl transferase |
| S. flexneri | Acc# AAF09026.1 & AAC39272.1 | 87% | Sugar transferases |
Additional homologs have been identified in diverse organisms including Synechocystis, Bacillus, and Streptomyces , suggesting that this protein family represents an ancient and widely distributed mechanism for glycoconjugate modification. The high degree of sequence conservation indicates strong selective pressure to maintain specific functional domains.
Cross-complementation studies have shown that GtrAB(IV) can functionally replace other GtrAB proteins of known function, indicating their conserved ability to bind and transfer glucose to a GtrC protein . This functional interchangeability supports the model that:
The basic enzymatic mechanism of glucose transfer to lipid carriers is conserved
Protein-protein interactions between GtrB and GtrA are maintained across different systems
The specificity of O-antigen modification is primarily determined by the GtrC component
These findings highlight the modular nature of the gtrABC system and suggest potential applications in synthetic biology for engineering novel glycosylation patterns.
Despite significant advances in understanding gtrB, several important questions remain:
Detailed atomic structure of gtrB and its complexes with substrates
Kinetic mechanisms of glucose transfer and rate-limiting steps
Regulatory networks controlling gtrABC expression beyond phase variation
Potential for engineering gtrB to accept non-native substrates for glycoengineering applications
Role of gtrB-mediated modifications in bacterial persistence within hosts
Addressing these questions will require interdisciplinary approaches combining structural biology, biochemistry, microbial genetics, and immunology.
Recent technological developments hold promise for deeper insights into gtrB function:
Cryo-electron microscopy for membrane protein structure determination
Native mass spectrometry for studying intact membrane protein complexes
CRISPR-Cas9 genome editing for precise manipulation of gtrABC systems
Single-molecule fluorescence techniques to observe gtrB activity in real-time
Synthetic biology approaches to create novel glycosylation pathways
These advanced methodologies could help resolve outstanding questions about the molecular mechanisms underlying gtrB function and potentially lead to applications in glycoengineering and antimicrobial development.